We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

144 hedge funds and large institutions have $986M invested in Foundation Medicine, Inc. in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $91M | Put options by funds: $23M

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

26% more capital invested

Capital invested by funds: $784M → $986M (+$203M)

13% more funds holding

Funds holding: 127144 (+17)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 42

Holders
144
Holders Change
+17
Holders Change %
+13.39%
% of All Funds
3.3%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
36
Increased
42
Reduced
42
Closed
17
Calls
$91M
Puts
$23M
Net Calls
+$68.1M
Net Calls Change
+$42.1M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
1
Gilder Gagnon Howe & Co
New York
$109M -$8.97M -121,630 -8%
BlackRock
2
BlackRock
New York
$108M -$2.92M -39,622 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$74.8M +$21.4M +289,528 +44%
Chevy Chase Trust
4
Chevy Chase Trust
Maryland
$69.3M -$13.9M -187,891 -18%
State Street
5
State Street
Massachusetts
$63.6M +$26.4M +357,604 +79%
OC
6
Oppenheimer & Co
New York
$56.1M -$8.86K -120 -0%
Lord, Abbett & Co
7
Lord, Abbett & Co
New Jersey
$48.3M +$1.3M +17,631 +3%
CC
8
Casdin Capital
New York
$41M
HCM
9
Hitchwood Capital Management
New York
$31.5M +$2.95M +40,000 +11%
Baillie Gifford & Co
10
Baillie Gifford & Co
United Kingdom
$30.7M +$6.14M +83,259 +27%
AAMU
11
Amundi Asset Management US
Massachusetts
$21.6M -$56.7K -768 -0.3%
BA
12
Boston Advisors
Massachusetts
$19.6M +$4.33M +58,630 +31%
PCM
13
Peregrine Capital Management
Minnesota
$19M -$2.97M -40,258 -14%
AllianceBernstein
14
AllianceBernstein
Tennessee
$15.4M -$8.06M -109,165 -36%
Northern Trust
15
Northern Trust
Illinois
$14.7M +$12.8K +173 +0.1%
PC
16
Polar Capital
United Kingdom
$13.6M +$12.8M +173,000 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$12.8M +$73.1K +990 +0.6%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$12M +$5.54M +75,034 +98%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$11.2M -$8.42M -114,130 -45%
Invesco
20
Invesco
Georgia
$10.9M +$10.2M +138,753 New
ECP
21
Elk Creek Partners
Colorado
$10.7M +$10M +136,138 New
ACM
22
Adalta Capital Management
New York
$10.2M -$26.2K -355 -0.3%
Jennison Associates
23
Jennison Associates
New York
$9.85M +$9.23M +125,096 New
Morgan Stanley
24
Morgan Stanley
New York
$8.84M +$4.58M +62,099 +124%
HCM
25
Highbridge Capital Management
New York
$8.49M +$7.95M +107,800 New

FMI Hedge Fund Activity: Q1 2018 in Review

144 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q1 2018, worth a combined $986M — up 26% from $784M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new FMI positions and 17 closed out — a net gain of 19 holders — while 42 added to existing stakes and 42 trimmed.

The largest buyer was State Street, adding an estimated $26.4M. The largest seller was Chevy Chase Trust, cutting an estimated $13.9M.

  • 144 institutional investors held Foundation Medicine, Inc. (FMI) as of Q1 2018, up from 127 in Q4 2017.
  • Funds reported $986M of Foundation Medicine, Inc. stock for Q1 2018, up 26% quarter-over-quarter.
  • 36 funds opened new Foundation Medicine, Inc. positions in Q1 2018 and 17 closed out, a net change of +19 holders.
  • The largest Foundation Medicine, Inc. buyer in Q1 2018 was State Street, an estimated $26.4M added.
  • The largest Foundation Medicine, Inc. seller in Q1 2018 was Chevy Chase Trust, an estimated $13.9M sold.

Based on aggregated 13F filings for Q1 2018.